Small dense low-density lipoprotein-lowering agents
- PMID: 32427116
- DOI: 10.1515/hsz-2019-0426
Small dense low-density lipoprotein-lowering agents
Abstract
Metabolic disorders, including obesity, diabetes, and hyperlipidemia, as well as cardiovascular diseases (CVD), particularly atherosclerosis, are still leading causes of death worldwide. Plasma levels of low-density lipoprotein (LDL) are currently being considered as a critical risk factor for the diseases mentioned above, especially atherosclerosis. Because of the heterogeneous nature of LDL, many studies have already been conducted on its subclasses, especially small dense LDL (sdLDL). According to available evidence, sdLDL levels can be considered as an ideal alternative to LDL levels for monitoring CVD and early diagnosis of atherosclerosis. Recently, several researchers have focused on factors that are able to decrease sdLDL levels and improve health quality. Therefore, the purpose of this study is to describe the production process of sdLDL particles and review the effects of pharmaceutical and dietary agents as well as lifestyle on sdLDL plasma levels. In brief, their mechanisms of action are discussed. Apparently, cholesterol and LDL-lowering compounds are also effective in the reduction of sdLDL levels. In addition, improving lipid profile, especially the reduction of triglyceride levels, appropriate regimen, and lifestyle can decrease sdLDL levels. Therefore, all the aforementioned parameters should be taken into consideration simultaneously in sdLDL levels reducing strategies.
Keywords: atherosclerosis; cardiovascular diseases (CVD); cholesterol; small dense low-density lipoprotein; triglyceride.
Similar articles
-
Small Dense Low-Density Lipoprotein Level in Newly Diagnosed Type 2 Diabetes Mellitus Patients With Normal Low-Density Lipoprotein.Cureus. 2023 Jan 18;15(1):e33924. doi: 10.7759/cureus.33924. eCollection 2023 Jan. Cureus. 2023. PMID: 36819362 Free PMC article.
-
[Possibility of New Circulating Atherosclerosis-Related Lipid Markers Measurement in Medical and Complete Medical Checkups: Small Dense Low-Density Lipoprotein Cholesterol and Lipoprotein Lipase].Rinsho Byori. 2016 Mar;64(3):298-307. Rinsho Byori. 2016. PMID: 27363222 Review. Japanese.
-
Small Dense Low Density Lipoprotein Cholesterol, Paraoxonase 1 and Lipid Profile in Postmenopausal Women: Quality or Quantity?Arch Med Res. 2015 Oct;46(7):534-8. doi: 10.1016/j.arcmed.2015.08.007. Epub 2015 Sep 5. Arch Med Res. 2015. PMID: 26348135
-
Effect of non-statin lipid lowering and anti-obesity drugs on LDL subfractions in patients with mixed dyslipidaemia.Curr Vasc Pharmacol. 2010 Nov;8(6):820-30. doi: 10.2174/157016110793563825. Curr Vasc Pharmacol. 2010. PMID: 20180768 Review.
-
Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis.Atherosclerosis. 2009 Feb;202(2):582-8. doi: 10.1016/j.atherosclerosis.2008.04.042. Epub 2008 May 1. Atherosclerosis. 2009. PMID: 18492490
Cited by
-
Excessive Visit-to-Visit Small and Dense Low-Density Lipoproteins Elevate Cerebral Small Vessel Disease Progression Risk in the Elderly.Front Neurol. 2022 Jun 29;13:851735. doi: 10.3389/fneur.2022.851735. eCollection 2022. Front Neurol. 2022. PMID: 35847226 Free PMC article.
-
Atherogenic Plasma Index or Non-High-Density Lipoproteins as Markers Best Reflecting Age-Related High Concentrations of Small Dense Low-Density Lipoproteins.Int J Mol Sci. 2022 May 3;23(9):5089. doi: 10.3390/ijms23095089. Int J Mol Sci. 2022. PMID: 35563477 Free PMC article.
-
Novel Pharmaceutical and Nutraceutical-Based Approaches for Cardiovascular Diseases Prevention Targeting Atherogenic Small Dense LDL.Pharmaceutics. 2022 Apr 9;14(4):825. doi: 10.3390/pharmaceutics14040825. Pharmaceutics. 2022. PMID: 35456658 Free PMC article. Review.
-
Decreased Low-Density Lipoprotein Cholesterol Level Indicates Poor Prognosis of Severe and Critical COVID-19 Patients: A Retrospective, Single-Center Study.Front Med (Lausanne). 2021 May 26;8:585851. doi: 10.3389/fmed.2021.585851. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34124081 Free PMC article.
-
Elevated Serum Small Dense Low-Density Lipoprotein Cholesterol May Increase the Risk and Severity of Coronary Heart Disease and Predict Cardiovascular Events in Patients with Type 2 Diabetes Mellitus.Dis Markers. 2021 May 10;2021:5597028. doi: 10.1155/2021/5597028. eCollection 2021. Dis Markers. 2021. PMID: 34046097 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical